166
Views
51
CrossRef citations to date
0
Altmetric
Research Article

Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes

, &
Pages 67-76 | Received 18 Jun 2012, Accepted 08 Sep 2012, Published online: 08 Oct 2012

References

  • Adcock IM, Caramori G. (2001). Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol, 79, 376–384.
  • Agarwal A, Gupta U, Asthana A, Jain NK. (2009). Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials, 30, 3588–3596.
  • Beck RSR, Guterres SS, Freddo RJ, Michalowski CB, Barcellos I, Funck JAB. (2003). Nanoparticles containing dexamethasone: physicochemical properties and anti-inflammatory activity. Acta Farm Bonaerense, 22, 11–15.
  • Bethune DS, Klang CH, de Vries MS, Gorman G, Savoy R, Vazquez J, Beyers R. (1993). Cobalt-catalysed growth of carbon nanotubes with single-atomic-layer walls. Nature, 363, 605–607.
  • Bianco A, Kostarelos K, Partidos CD, Prato M. (2005). Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb), 5, 571–577.
  • Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, Bergamaschi A, Mustelin T. (2006). Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett, 160, 121–126.
  • Choi JS, Ko KS, Park JS, Kim YH, Kim SW, Lee M. (2006). Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation. Int J Pharm, 320, 171–178.
  • Gabizon A, Martin F. (1997). Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs, 54 Suppl 4, 15–21.
  • Gabizon A, Shmeeda H, Barenholz Y. (2003). Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet, 42, 419–436.
  • Gruneich JA, Price A, Zhu J, Diamond SL. (2004). Cationic corticosteroid for nonviral gene delivery. Gene Ther, 11, 668–674.
  • Gupta U, Dwivedi SK, Bid HK, Konwar R, Jain NK. (2010). Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int J Pharm, 393, 185–196.
  • Hermanson GT. (1991). Bioconjugate Technique. USA: Academic Press, 316–322.
  • Huang H, Yuan Q, Shah JS, Misra RD. (2011). A new family of folate-decorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery response. Adv Drug Deliv Rev, 63, 1332–1339.
  • Iijima S, Ichihashi T. (1993). Single-shell carbon nanotubes of 1-nm diameter. Nature, 364, 737–737.
  • Iijima S. (1991). Helical microtubules of graphite carbon. Nature, 354, 56–58.
  • Jain AK, Dubey V, Mehra NK, Lodhi N, Nahar M, Mishra DK, Jain NK. (2009). Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization. Nanomedicine, 5, 432–442.
  • Jain AK, Mehra NK, Lodhi N, Dubey V, Mishra D, Jain NK. (2007). Carbon nanotubes and their toxicity. Nanotoxicol, 1, 167–197.
  • Ji Z, Lin G, Lu Q, Meng L, Shen X, Dong L, Fu C, Zhang X. (2012). Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. J Colloid Interface Sci, 365, 143–149.
  • Kam NWS, Liu Z, Dai H. (2005). Carbon nanotubes as intracellular transporters for protein and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed, 44, 1–6.
  • Kaminskas LM, McLeod VM, Kelly BD, Sberna G, Boyd BJ, Williamson M, Owen DJ, Porter CJ. (2012). A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. Nanomedicine, 8, 103–111.
  • Kayat J, Gajbhiye V, Tekade RK, Jain NK, (2010). Pulmonary toxicity of carbon nanotubes. Nanomed: Nanotech Biol Med, 7, 40–49.
  • Kesharwani P, Ghanghoriya R, Jain NK. (2012) Carbon nanotubes exploration in cancer cell lines. Drug Discov Today, 17–18, 1023–1030.
  • Lay CL, Liu HQ, Tan HR, Liu Y. (2010). Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics. Nanotechnology, 21, 065101.
  • Li J, Zhang Y. (2006). Cutting of multi walled carbon nanotubes. Appl Surf Sci, 252, 2944–2948.
  • Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X, Dai H. (2008). Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res, 68, 6652–6660.
  • Liu Z, Sun X, Nakayama-Ratchford N, Dai H. (2007). Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano, 1, 50–56.
  • Lu YJ, Wei KC, Ma CC, Yang SY, Chen JP. (2012). Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Colloids Surf B Biointerfaces, 89, 1–9.
  • Maria GC, Paola M, Luigi L, Zhouhai Z. (2002). Release of dexamethasone from PLGA nanoparticles entrapped into dextran/poly(vinyl alcohol) hydrogels. J Mat Sci Mat Med, 13, 265–269.
  • Mehra NK, Jain AK, Lodhi N, Raj R, Dubey V, Mishra D, Nahar M, Jain NK. (2008). Challenges in the use of carbon nanotubes for biomedical applications. Crit Rev Ther Drug Carrier Syst, 25, 169–206.
  • Meng L, Zhang X, Lu Q, Fei Z, Dyson PJ. (2012). Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors. Biomaterials, 33, 1689–1698.
  • Mishra V, Gupta U, Jain NK. (2010). Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes. Pharmazie, 65, 891–895.
  • Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand JP, Prato M, Kostarelos K, Bianco A. (2004). Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed Engl, 43, 5242–5246.
  • Park TG, Yoo HS. (2006). Dexamethasone nano-aggregates composed of PEG-PLA-PEG triblock copolymers for anti-proliferation of smooth muscle cells. Int J Pharm, 326, 169–173.
  • Pruthi J, Mehra NK, Jain NK. (2012). Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes. J Drug Target, 20, 593–604.
  • Reddy LH, Murthy RS. (2004). Pharmacokinetics and biodistribution studies of Doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 148, 161–166.
  • Ren J, Shen S, Wang D, Xi Z, Guo L, Pang Z, Qian Y, Sun X, Jiang X. (2012). The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials, 33, 3324–3333.
  • Shen J, Huang W, Wu L, Hu Y, Ye M. (2007). Thermo-physical properties of epoxy nanocomposites reinforced with amino-functionalized multi-walled carbon nanotubes. Composites: Part A, 38, 1331–1336.
  • Simons SS Jr, Thompson EB. (1981). Dexamethasone 21-mesylate: an affinity label of glucocorticoid receptors from rat hepatoma tissue culture cells. Proc Natl Acad Sci USA, 78, 3541–3545.
  • Singh P, Gupta U, Asthana A, Jain NK. (2008). Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjug Chem, 19, 2239–2252.
  • Sobhani Z, Dinarvand R, Atyabi F, Ghahremani M, Adeli M. (2011). Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube. Int J Nanomedicine, 6, 705–719.
  • Taghdisi SM, Lavaee P, Ramezani M, Abnous K. (2011). Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes. Eur J Pharm Biopharm, 77, 200–206.
  • Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, Briand JP, Gennaro R, Prato M, Bianco A. (2005). Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl, 44, 6358–6362.
  • Zhang X, Meng L, Lu Q, Fei Z, Dyson PJ. (2009). Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials, 30, 6041–6047.
  • Zhao Y, Xing G, Chai Z. (2008). Nanotoxicology: Are carbon nanotubes safe? Nat Nanotechnol, 3, 191–192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.